Pyridine substituted furan derivatives as Raf kinase inhibitors
    5.
    发明授权
    Pyridine substituted furan derivatives as Raf kinase inhibitors 失效
    吡啶取代的呋喃衍生物作为Raf激酶抑制剂

    公开(公告)号:US07375105B2

    公开(公告)日:2008-05-20

    申请号:US10488650

    申请日:2002-09-05

    CPC分类号: C07D405/04 C07D405/14

    摘要: Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy. Wherein X is O, CH2 CO, S or NH, or the moiety X—R1 is hydrogen; Y1 and Y2 independently represent CH or N; Ar is a mono- or fused bicyclic aromatic or heteroaromatic group which may be optionally substituted; one of X1 and X2 is selected from O, S or NR11 and the other is CH, wherein R11 is hydrogen, C1-6alkyl, aryl or arylC1-6alkyl.

    摘要翻译: 化合物及其作为药物的用途,特别是用作治疗神经创伤性疾病,癌症,慢性神经变性,疼痛,偏头痛和心脏肥大的Raf激酶抑制剂。 其中X是O,CH 2 CO,S或NH,或者X-R 1部分是氢; Y 1和Y 2独立地表示CH或N; Ar是可以任选取代的单或二稠合双环芳族或杂芳族基团; X 1和X 2之一选自O,S或NR 11,另一个是CH,其中R 11, / SUP>是氢,C 1-6烷基,芳基或芳基C 1-6烷基。